← Back
Data updated: Jun 28, 2026
HORIZON
Specialty Pharmaceuticals
HORIZON is a specialty pharmaceutical company with 5 FDA-approved products.
2010
Since
5
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules
HORIZON's Key Drugs
HORIZON's core commercial portfolio centers on PROCYSBI — its most strategically important drugs approved in the last 15 years.
HORIZON's Recent FDA Approvals
New NDA/BLA approvals for HORIZON over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
HORIZON's Therapeutic Areas
Disease areas where HORIZON has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
HORIZON Pipeline Snapshot
Active clinical trials for HORIZON across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling